Subscribe To
Moderna withholds declaring ‘early success' for its influenza vaccine
Shares of Moderna Inc (NASDAQ: MRNA) are trading down on Tuesday after the biotechnology company said it did not have enough data to declare “early ...
April 11, 2023, 11:54 am
Moderna says there are not enough cases to declare early success for its mrna flu vaccine
CNBC's Meg Tirrell reports on news from Moderna that it will delay results from its flu vaccine trials....
April 11, 2023, 11:51 am
Moderna stock falls after vaccines update
The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out six new products with “sizable markets.”...
April 11, 2023, 11:48 am
Moderna stock slides following experimental flu vaccine setback
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the decline in stock for Moderna....
April 11, 2023, 9:59 am
Vaccines for lyme disease and norovirus? moderna working on shots targeting tick-borne infection and vomiting bug
Lyme is Moderna's first attempt at creating a vaccine for a bacterial infection....
April 11, 2023, 9:52 am
Moderna stock slides despite positive vaccines update. here's why.
The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out six new products with “sizable markets.”...
April 11, 2023, 8:57 am
Moderna says it expects up to $15 billion in sales of covid, rsv, flu vaccines in 2027
Moderna said it sees a corresponding operating profit from its Covid, RSV, and flu vaccines in the rang...
April 11, 2023, 8:54 am
Moderna is developing a vaccine candidate against lyme disease that would be its first bacterial vaccine
Moderna Inc. MRNA, +1.19% outlined its clinical goals for its mRNA platform on Tuesday to mark its 4th Vaccin<...
April 11, 2023, 7:27 am
Moderna expects to have cancer and heart disease vaccines ready by the end of the decade
Moderna Therapeutics Inc is aiming to develop life-saving vaccines for cancer, heart disease, and othe...
April 11, 2023, 3:27 am
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030
Moderna's chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new v
April 10, 2023, 3:28 pm
Moderna (mrna), merck's cancer jab gets ema's prime tag
The EMA grants PRIME designation to Moderna's (MRNA) personalized cancer vaccine candidate combined wit...
April 10, 2023, 12:56 pm
Moderna surges on a key win for its merck-partnered cancer vaccine in europe
Moderna stock inched ahead Monday after European regulators granted its Merck-partnered personalized cancer va...
April 10, 2023, 10:01 am
Pfizer: trying to acquire growth
Pfizer has used the vaccine boom and related profits from the pandemic to pursue a flurry of deals. The...
April 9, 2023, 6:33 am
Fcmi parent now owns 42.8% of vaccinex
Fintel reports that Fcmi Parent has filed a 13D/A form with the SEC disclosing ownership of 23.49MM shares of V...
April 6, 2023, 10:23 pm
Allergy therapeutics agrees bail out by two large shareholders
Allergy Therapeutics has arranged a financing package from two of the major shareholders that will enable it to carry on with planned trials of its ha...
April 6, 2023, 11:20 am
Vbi vaccines (vbiv) down 53% on initiating restructuring plans
VBI Vaccines (VBIV) will focus on its HBV vaccine produc...
April 5, 2023, 12:56 pm
Vbi vaccines to focus on hep b treatments, conduct 1-for-30 reverse stock split
VBI Vaccines Inc. VBIV, -0.96% said Tuesday it is planning to focus its efforts on hepatitis B, as part...
April 4, 2023, 8:14 am
1 stock to buy and 1 to avoid before the next bull market
Pinterest is performing decently despite headwinds, and it has massive opportunities ahead. Novavax's hopes are fading away as the coronavirus v...
April 4, 2023, 7:07 am
Gsk: will vaccines do the trick? this leading bank has its say
Deutsche Bank repeated its ‘buy' advice and 1,700p price target for shares in GSK PLC (LSE:GSK, NYSE:GSK) in an update which assessed the news flow ...
April 3, 2023, 12:19 pm
Could this move by johnson & johnson equal billions for moderna?
J&J is dropping out of the adult RSV vaccine race. This leaves the market to Moderna, Pfizer, and GSK; ...
April 2, 2023, 5:30 am